Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Annual Report 2021 is posted on OTCMARKETS.COM
In case you didn’t write it down, today’s info for the conference call.
4:30 EST
857-232-0157
Code 422095
All those tornado touchdowns created a lot of work for National Storm Recovery. Future revenues for the next quarter.
I have emailed Scott a few times and he doesn’t respond. So, good luck with that. Most of the NFTs coming online are going under, and I presume this will too.
You don’t recruit these types of people for small companies, so there must be a national plan in the works.
Here’s the news!!
Progressive Care Strengthens Management Team with Industry Experts
MARCH 7, 2022
Bolsters Operations in Logistics and Fulfillment and Compliance
Miami, FL – March 3, 2022 – Globe Newswire via NewMediaWire – Progressive Care Inc. (OTCQB: RXMD) (the “Company”), a personalized healthcare services and technology provider, is pleased to announce the appointment of industry experts, Courtney Thomas as Logistics Manager at PharmcoRx Logistics and Fulfillment Department, and Andreas Grant as Compliance Manager of the PharmcoRx 340B Program.
“We are glad to be able to grow PharmcoRx’s management team with industry experts who will help us deliver a world-class experience to our customers. Courtney’s extensive logistics and fulfillment experience is the right fit to streamline our delivery department capabilities,” stated Alan Jay Weisberg, CEO of the Company. “We are excited to welcome Andreas with an impressive background and experience in 340B programs. Andreas will play a key role in helping our 340B program grow while maintaining high levels of customer service, reporting, and overall program compliance.”.
Courtney Thomas has joined PharmcoRx as Logistics Manager. Courtney will oversee the implementation strategies, analysis and optimization of processes related to the Logistics and PharmcoRx Fulfillment Department. She has over seven years of experience managing and coordinating logistics for Amazon Fulfillment, where she held the positions of Warehouse Associate, Trainer, Process Assistant, Logistics Manager, and Area Manager. Courtney completed four years of Virginia Commonwealth University pursuing a bachelor’s degree in biology and chemistry. Courtney’s expertise is in logistics, fulfillment, and customer service.
Andreas Grant has joined PharmcoRx as 340B Compliance Manager. Andreas will oversee PharmcoRx Pharmacy 340B program including compliance, reporting, and fulfillment of government subsidized medications for underserved communities covered under the Health Resources and Services Administration (HRSA). He has over twelve years of experience in the healthcare industry holding several positions at large healthcare corporations such as McKesson Macro Helix, 340Basics, Rx Strategies, and Jackson Health System. Andreas pursued a bachelor's degree in healthcare administration from Thomas Edison State College.
Progressive Care, Inc.
Progressive Care, Inc. (OTCQB: RXMD), through its subsidiaries, is a Florida health services organization and provider of prescription pharmaceuticals, compounded medications, provider of tele-pharmacy services, the sale of anti-retroviral medications, medication therapy management (MTM), the supply of prescription medications to long-term care facilities, and health practice risk management.
For more information about Progressive Care, please visit the company’s website.
Connect and stay in touch with us on social m
Is Armen giving the presentation or is it Jay?
100 million shares???
Iliad’s shares are being monitored weekly.
Here we go!
Progressive Care Expands Its Corporate Services with Enhanced COVID-19 Platform Capabilities
FEBRUARY 15, 2022
Ability to Schedule On-site Testing, Pay and Receive Results Online Within Minutes
Miami, FL – February 16, 2022 – Globe Newswire via NewMediaWire – Progressive Care Inc. (OTCQB: RXMD) (the “Company”), a personalized healthcare services and technology provider, is pleased to announce its expansion into corporate-focused services with enhanced technological capabilities to help businesses manage COVID-19 testing and vaccination in the workplace.
Progressive Care’s PharmcoRx.com platform now allows business managers or their appointed administrators to schedule COVID-19 testing for large groups online, select a preferred testing location or request an on-site visit, receive and securely share their employees’ testing results, as well as securely communicate with the pharmacy’s lab staff in real time.
Carlos Rangel, Head of Digital Transformation of Progressive Care, stated, “We have been able to provide our institutional clients with a complete platform for COVID-19 management in the workplace including the performance of on-site testing and vaccinations with real-time reporting through our patient portal. We look forward to continuing to build strong relationships in the corporate space and we are excited about our technology capabilities.”
Due to the latest COVID-19 surge, organizations are turning to companies such as Progressive Care for COVID-19 management solutions that provide COVID-19 PCR and Antigen test results within 15 to 30 minutes. The Company’s COVID-19 team has established working relationships with top entertainment and media production companies in the United States, large manufacturers, embassies, and Fortune 500 companies. Progressive Care currently operates over 40 COVID-19 rapid PCR test analyzers and has generated over $4 million in testing revenue in 2021. Its online COVID-19 platform comes as the preface of a more comprehensive initiative to bring rapid COVID-19 point of care PCR testing nationwide.
Alan Jay Weisberg, CEO and Chairman of the Board, added, “Despite adverse labor conditions and ongoing challenges brought by COVID-19 variants, our team of dedicated professionals was able to successfully deliver on our mission to protect workplaces through the continued development of our digital platform capabilities to stay at the vanguard of healthcare technology.”
Progressive Care, Inc.
Progressive Care, Inc. (OTCQB: RXMD), through its subsidiaries, is a Florida health services organization and provider of prescripti
Yes indeed. I’m an old time Tom Petty fan.
I had the last dance with Mary Jane. Lol
JANE may be getting ahead of the curve when RXMD uplists.
Quarterly earnings report should be released on Tuesday or Wednesday. Should be a great report with all the expansions.
I can’t wait until I read the PR saying RXMD is debt free.
Also, since that revenue stream won’t last much longer perhaps RXMD should use those funds to retire debt.
News release!!
Progressive Care’s PharmcoRx Gains Status as Approved COVID-19 Test Vendor in the U.S. for Travel to Beijing Winter Olympic Games in China
FEBRUARY 2, 2022
Miami, FL – February 2, 2022 – (GLOBE NEWSWIRE)-via NewMediaWire – Progressive Care Inc. (OTCQB: RXMD) (“Progressive Care” or the “Company”), a personalized healthcare services and technology provider, is pleased to announce that its PharmcoRx subsidiary’s gained status as one of the 35 approved COVID-19 test vendors in the U.S. for travel to the People’s Republic of China (“China”), for the Beijing Winter Olympic Games.
For a complete list of the approved Covid-19 test vendors from the Chinese Embassy website, please visit: http://www.china-embassy.org/eng/bwos/
Alan Jay Weisberg, Chairman and Chief Executive Officer of Progressive Care, commented, “With the upcoming start of the Olympic Games in Beijing, China, we are honored to have been one of the selected vendors for COVID-19 testing of U.S. travelers bound for China. We believe our timeliness, accuracy and service differentiate us from other Covid-19 test vendors and were the basis of our selection.”
Progressive Care, Inc.
Progressive Care, Inc. (OTCQB: RXMD), through its subsidiaries, is a Florida health services organization and provider of prescription pharmaceuticals, compounded medications, provider of tele-pharmacy services, the sale of anti-retroviral medications, medication therapy management (MTM), the supply of prescription medications to long-term care facilities, and health practice risk management.
For more information about Progressive Care, please visit the company’s website.
Connect and stay in touch with us on social media:
Progressive Care Inc.
https://www.progressivecareus.com/
https://twitter.com/ProgressCareUS
PharmCoRx
We have more news!!
Progressive Care Sees 620% Annual Growth in COVID-19 Testing to $4.3 Million Revenue
FEBRUARY 1, 2022
Miami, FL – February 1, 2022 – Globe Newswire via NewMediaWire – Progressive Care, Inc. (OTCQB: RXMD) (the “Company” or “Progressive Care”), a personalized healthcare services and technology provider, is pleased to announce it has continued to experience strong demand for its COVID-19 testing. Fourth quarter and annual 2021 COVID-19 testing revenue increased 132% and 620%, to $1.4 million and $4.3 million, respectively.
Alan Jay Weisberg, Chairman and Chief Executive Officer of Progressive Care, commented, “During 2021, we launched an aggressive expansion of our COVID-19 testing service, which contributed to accelerated revenue growth rates. The fourth quarter was particularly strong, as we continued to market our PharmcoRx brand to corporate clients as a one-stop shop for COVID-19 testing and vaccine management solutions. We believe our positioning as a leading Florida health services organization and provider of COVID-19 testing and vaccine services will build additional value for our shareholders.”
Progressive Care currently operates over 40 COVID-19 Rapid PCR Test analyzers. The Company has built strong relationships with its corporate clients and successfully scaled its infrastructure capable of testing up to 1,000 patients a day, with results in as little as 15 minutes.
Progressive Care provides COVID-19 testing services using the FDA’s Emergency Use Authorization (“EUA”) guidelines, featuring Polymerase Chain Reaction (“PCR”) and Antigen testing systems that produce rapid detection of the SARS-CoV-2 virus, and Antibody testing to detect the presence of IGG and IGM antibodies in the blood.
The systems the Company uses for Rapid Detection of the SARS-CoV-2 virus is a molecular test using a lab technique called PCR, an antigen-based testing system designed to detect proteins from the virus that causes COVID-19, and COVID-19 IgG/IgM Rapid Test Cassette authorized for the detection of antibodies to SARS-CoV-2 in human venous whole blood.
Progressive Care testing sites are equipped with analyzers capable of detecting positive or negative COVID-19 results within minutes. Each Site is operated by clinically trained Pharmacy staff and administering tests on and off site. The Company has established a reputation as a reliable testing partner and currently provides testing services to international travelers and international airlines, chain restaurants, U.S. and international production and entertainment companies, and local healthcare communities. The Company has been able to build an Ecosystem that allows a patient, employer, or coordinator in-charge to chat with the Company’s support team, schedule a test, pay for the test, and at the point of arrival to the site create a profile and access test results by simply scanning a
QR code from a mobile device. Using the same Ecosystem, the Company’s support staff can manage the entire patient’s journey and provide automated reporting of the results to regulatory authorities, supervisors and coordinators in-charge.
Progressive Care, Inc.
Progressive Care, Inc. (OTCQB: RXMD), through its subsidiaries, is a Florida health services organization and provider of prescription pharmaceuticals, compounded medications, provider of tele-pharmacy services, the sale of anti-retroviral medications, medication therapy management (MTM), the supply of prescription medications to long-term care facilities, and health practice risk managemen
ClearMetx will allow RXMD to go national on the 340B contracts.
If RXMD wants to go that far let’s include the whole Eastern seaboard since they are licensed in many of those states.
The Tampa area would be a great target.
You actually get paid twice after the company converts the waste to lumber, mulch and assorted colored wood chip.
Wait until the quarterly report. This should have great a great quarter. My sell order is in at $20.
Progressive Care to settle with 2 investors
Progressive Care (OTCQB:RXMD) reached an agreement to settle its demand against two investors, Chicago Venture Partners (CVP) and Iliad Research and Trading.
Under the settlement agreement, CVP agreed to pay the company $175K. Upon receipt of payment, the securities purchase agreement between the company and CVP will be terminated.
Iliad agreed not to sell any common shares of the company or submit any redemption notices as long as no default occurs under the Iliad Note. The company also has the right to request, on a weekly basis, a document sufficient to show the number of shares held by Iliad.
The company has the right to prepay the Iliad Note for an amount in cash equal to 105% of the portion of the outstanding balance elected to be prepaid.
The two parties also extended the maturity date of the Iliad Note to April 15, 2022.
The balance of the Iliad Note decreased in the amount of $180K, effective May 31, 2021. If the Note is not repaid by February 16, 2022, the outstanding balance of the Note will increase in the amount of $100K.
Get your hands on small-cap stocks with explosive upside. Try Seeking Alpha Premium for Free »
Related Analysis
Weak Consumer Sentiment A Headwind For Fed Rate Hikes?
Looking for some short-term wins? Unlock Seeking Alpha’s Top Rated Stocks »
2 Great 'Preferred Stocks' To Buy And Hold Forever
Jumping On The ILF Bandwagon
Wall Street Breakfast: Russian Stocks Slump (Podcast by Pimm Fox)
See Latest Analysis »
These 3 Hidden Stocks Are Giving a Powerful Buy Signal NOW!
Learn More?»
Thanks for the update Mr Mike. There were a few mentions that I forgot about.
New COVID at-home test dangerous and misleading: but everybody’s doing it, so who cares, right?
by Jon Rappoport
(To read about Jon's mega-collection, The Matrix Revealed, click here.)
Recently, I’ve been writing fiction, satire, parody, to expose the insanity of the pandemic scam. This article is not that. This article is fact. Buckle up.
Since the beginning of the so-called pandemic, I’ve been attacking the value of the PCR diagnostic test from many angles. The primary angle, as my readers know, is: SARS-CoV-2 was never isolated, never proved to exist.
However, I’ve also ventured into the bubble world where a few billion people blindly accept the existence of the virus---and I’ve shown that even within that world, the internal contradictions and lies abound.
One again, now, I’m entering that bubble world, since the powers-that-be are widely promoting the use of an at-home test for the “virus.” This test is self-administered. No doctor, nurse, or technician is present. What could possibly go wrong, as millions of people perform the test on themselves?
Well, let’s lead off with DANGER.
The reference is an undated FDA document titled, “BinaxNOWTM COVID-19 Antigen Self TEST.” The Binax test kit is manufactured by Abbott.
Here is the key quote: “The Reagent Solution [included in the test kit] contains a harmful chemical (see table below). If the solution contacts the skin or eye, flush with copious amounts of water. If irritation persists, seek medical advice…”
Then the FDA document lists that harmful chemical: sodium azide.
Just how harmful is it?
For an answer, let’s look at a CDC document titled, “Facts About Sodium Azide.” We find this statement:
“Sodium azide is a rapidly acting, potentially deadly chemical that exists as an odorless white solid.”
Then there is this: “Sodium azide prevents the cells of the body from using oxygen. When this happens, the cells die. Sodium azide is more harmful to the heart and the brain than to other organs, because the heart and the brain use a lot of oxygen.”
Yes, as with all poisons, the degree of damage depends on the dosage, but you decide whether “potentially deadly,” as the CDC describes sodium azide, signifies a significant risk.
If you read the FDA document I referenced above, you’ll see that the reagent containing sodium azide is involved in the self-administered COVID test, and the whole test procedure is complex enough to allow fumbles and mistakes---such as a spill of the “deadly chemical.”
Don’t believe me? Try this FDA quote on for size: “To perform the test, an anterior nasal swab specimen is collected by the patient, then 6 drops of extraction reagent from a dropper bottle are added to the top hole of the swab well. The patient sample is inserted into the test card through the bottom hole of the swab well, and firmly pushed upwards until the swab tip is visible through the top hole. The swab is rotated 3 times clockwise and the card is closed, bringing the extracted sample into contact with the test strip. Test results are interpreted visually at 15 minutes based on the presence or absence of visually detectable pink/purple colored lines.”
See what I mean? Good luck.
Now let’s move on to the second problem with this at-home self-performed COVID test: it’s grossly misleading. The results are ambiguous.
The FDA document I’ve been quoting contains this gem: “The BinaxNOW COVID-19 Antigen Self Test does not differentiate between SARS-CoV and SARS…CoV-2.”
BOOM. In other words, a positive test, indicating infection, could mean nothing more than infection with the 2003 “SARS virus”---and that “epidemic” was a dud. But wait, there’s more:
“Positive results do not rule out bacterial infection or co-infection with other viruses. The agent detected may not be the definite cause of disease.”
Double trouble. The person who tests positive could simply be housing bacteria in his body, AND whatever germ the test is detecting may not even be causing disease.
Other than that, the at-home test is perfect.
This Abbott BinaxNow at-home COVID test is the market leader. About 75% of all retail test-kit sales in the US come from Abbott.
Back in the early spring of 2020, I told you the test was the key to faking the pandemic. Now the government wants the population to perform the test-fakery on themselves. With, of course, the added danger of exposing themselves to a highly destructive chemical in the process.
But don’t worry, be happy. On many days of every week, little Tony Fauci will appear on television and inform you that testing is necessary, and he’ll omit grisly details. Trust him.
And then march forward, secure in the knowledge that lies and omissions keep us safe.
~~~
(The link to this article posted on my blog is here -- with sources.)
(Follow me on Gab at @jonrappoport)
Use this link to order Jon's Matrix Collections.
The PCR test was always a false test from the get go. It never detected a virus, only a protein spike which could be associated with a virus, any virus including the flu viruses.
Well mister, this idiot hasn’t been sick since the late 80’s. At that time I stopped taking any kind of Pharma drugs. Been taking natural herbs and supplements, which includes vitamin D and Zinc, since then. I have not been sick in 35 years because I maintain a high immunity. Best health care plan around. Mother Nature provides all the necessary ingredients to keep your body healthy. And I am 70 years old , and can still do everything a 35 year old athlete can do. So, who’s the idiot?
Whatever happened to the seasonal flu, did that get eradicated???
Think of the new Directors as new connections. I believe RXMD is still moving in the right direction.
News!!
Share Share
Tweet Tweet
Forward Forward
Progressive Care Announces Appointment of Two New Board Members to the Company’s Board of Directors
Read more
MIAMI, FL – December 22, 2021 – Progressive Care Inc. (OTCQB: RXMD) (“Progressive Care” or the “Company”), a personalized healthcare services and technology company, is pleased to announce that the Company has appointed Birute Norkute and Joseph Ziegler to join the Company’s Board of Directors.
“We are truly excited to include both Birute and Joseph to the Company’s Board,” commented Alan Jay Weisberg, CEO of Progressive Care. “We strongly believe that Joseph’s deep knowledge in healthcare, finance, and accounting with strong regulatory oversight and Birute’s operating, practical experience and in-depth expertise in healthcare regulations and processes will help the Company meet its corporate goals and drive shareholder value over the short, intermediate, and long term.”
Mr. Ziegler is currently the Chief Financial Officer of DAS Health, a private-equity owned provider of IT Services to healthcare providers. Mr. Ziegler previously served as CFO for Encompass Onsite, where he led a team through a period of rapid growth driven by acquisitions and new customer onboarding while improving the financial infrastructure of the business.
Prior to joining Encompass, he held multiple roles as a CFO in the healthcare industry, including Private Equity backed specialty pharmacy Biomatrix, successfully driving top-line growth from $60 million to $500 million during his tenure with the company. Prior to serving as CFO of Biometrix, Mr. Ziegler served as CFO of Novis Pharmaceuticals, driving the company’s growth from $60 million to $200 million during his tenure and led the company’s sales process to strategic acquirer Cardinal Health. He graduated from Florida Atlantic University with an MBA following a BS in finance.
Ms. Norkute has been a key part of Progressive Care and its/our pharmacy operations team since 2008 and has been leading the Company’s operations since 2013. She stands out as the driving force behind a number of critical accomplishments. As the chief architect of the operational model for ensuring medication adherence, her work is reflected in the Company’s consistent 5-star performance ratings in pharmacy dispensing and medication therapy management.
Before ascending to her current role as COO, Birute controlled budgetary compliance for PharmCoRx locations leading to efficiencies that were often superior to those of automated systems. She also has strong experience managing the Company’s IT infrastructure to ensure current protocols are in place for HIPAA compliance and technological efficiency.
For more information about Progressive Care, please visit the company’s website.
Connect and stay in touch with us on social media:
Progressive Care Inc.
https://www.progressivecareus.com/
https://twitter.com/ProgressCareUS
PharmCoRx
https://www.pharmcorx.com/
https://twitter.com/PharmCoRx
ClearMetrX
https://www.clearmetrx.com/
https://www.facebook.com/clearmetrx/
About Progressive Care:
Progressive Care Inc. (OTCQB: RXMD), through its subsidiaries, is a Florida health services organization and provider of Third-Party Administration (TPA), data management, COVID-19 related diagnostics and vaccinations, 340B contracted pharmacy services, prescription pharmaceuticals, compounded medications, provider of tele-pharmacy services, the sale of anti-retroviral medications, medication therapy management (MTM), the supply of prescription medications to long-term care facilities, and health practice risk management.
Cautionary Disclosure Regarding Forward-Looking Statements
Forward-Looking Statements contained herein that are not based upon current or historical fact are forward-looking in nature and constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such forward-looking statements reflect the Company’s expectations about its future operating results, performance, and opportunities that involve substantial risks and uncertainties. When used herein, the words “anticipate,” “believe,” “estimate,” “upcoming,” “plan,” “target,” “intend” and “expect” and similar expressions, as they relate to Progressive Care Inc., its subsidiaries, or its management, are intended to identify such forward-looking statements. These forward-looking statements are based on information currently available to the Company and are subject to a number of risks, uncertainties, and other factors that could cause the Company’s actual results, performance, prospects, and opportunities to differ materially from those expressed in, or implied by, these forward-looking statements.
Public Relations Contact:
Carlos Rangel
carlosr@pharmcorx.com
?
Find Out More
Facebook
Twitter
Link
Website
Copyright © 2021 Progressive Care, All rights reserved.
You are receiving this email because you opted in via our website.
Our mailing address is:
Progressive Care
901 North Miami Beach Blvd
Suite 1 and 2
North Miami Beach, FL 33162
Add us to your address book
Want to change how you receive these emails?
You can update your preferences or unsubscribe from this list.
Email Marketing Powered by Mailchimp
Your welcome. It’s around 50 pages long, but very detailed. I think uplisting won’t be a problem. Now we need the PR people to get the word out.
You can go to the SEC website and put in a filings alert and it will be emailed to you when filings are released.
Your welcome
Share price won’t be listed until RXMD is ready to uplist and get SEC approval.
No weed, Scott is into NFT business now.
Think 340B. That’s where future revenues will increase.
Data Management Services. We have begun transitioning from a pharmacy centered organization focusing on dispensing to an organization that provides data management services and health technology to pharmacies. We believe that data management for frontline and independent providers, 340B Covered Entities, and pharmacies will have increasing importance as health systems evolve to become virtual and digitized. Increasing focus on performance, margins, and quality, means that our models and platforms will have strategic value through our roots in day-to-day care management. Data management services will become an increasing driver of growth and development for us with its higher margins, and diverse monetization pathways.
Filing: SEC.report/Document/0001213900-21-063740/
Form S-1/A has been filed by:
: Progressive Care Inc.
IPO Investment Prospectus accepted on 2021-12-07 00:00:00
You received this notification because an SEC filing has was made in the EDGAR system matching a company you subscribed to notifications for.
Manage your company subscriptions, notification level, or unsubscribe at https://sec.report/notifications.php
Click here to unsubscribe from all emails ever.
Thanks Charlie.